Clinical area: Gynaecology - Digital health technologies to help manage the symptoms of the menopause

Why:

• Menopause usually affects women between the ages of 45 and 55, but it can naturally happen earlier or, after medical or surgical treatments.
• Menopause and perimenopause can cause symptoms like vasomotor symptoms (hot flushes/night sweats), mood disturbances, changes to menstrual cycle and period problems, poor sleep and deteriorating cognitive function (brain fog).
• New digital health technologies emerged during the COVID-19 pandemic, including use of mobile health apps, telemedicine, and data analytics to improve health systems.
• These technologies are enabling women to recognise, understand, and manage their own menopausal symptoms helping to improve their own health and wellbeing and reducing pressures on the NHS.

Products in scope:

Digital health technologies should meet the following criteria:

• Are intended for use by women with perimenopause, menopause, or women with more complex menopause needs, such as those with early menopause or after cancer.
• Could be used to treat mental or physical symptoms of menopause and perimenopause.
• Meet the standards within the digital technology assessment criteria (DTAC), including the criteria to have a CE or UKCA mark where required.
• Products may also be considered if they are actively working towards required CE or UKCA mark, have been deployed in a small number (2-10) of NHS sites or comparable clinical providers internationally.

If your product is in development, the NHS Innovation Service can help support you meet these standards and other requirements.

Further information:

If you have an innovation that meets that need, create an NHS Innovation Service account and fill in your innovation record to start receiving support for this innovation.